The initial offering period for the tender offer expired at 12:00 midnight, New York City time, at the end of Thursday, November 8, 2007, with approximately 37.9 million shares of ViaCell common stock being tendered, including approximately 6.8 million shares tendered under guaranteed delivery procedures, for $7.25 per share. All shares that were validly tendered and not withdrawn have been accepted for purchase. The shares tendered and accepted for purchase represent more than 90% of the outstanding shares of ViaCell common stock.
PerkinElmer intends to promptly acquire all of the remaining ViaCell shares by means of a short-form merger under Delaware law at the same price per share paid in the tender offer. Upon completion of the merger, ViaCell will become an indirect wholly owned subsidiary of PerkinElmer, Inc.